Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiome changes with La Roche-Posay Effaclar Duo plus versus topical retinoic acid and benzoyl peroxide in mild acne vulgaris
TCTR20210531009Phase 4Completed
- Sponsor
- L'Oréal
- Start
- Mar 2021
- Countries
- 1
01
Overview
Phase 4 trial in acne vulgaris (2 arms), sponsored by L'Oréal. Primary endpoint: Change in bacterial microbiome. Started Mar 2021; status: completed.
02
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20210531009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210531009.